BEA 2180 BR - rising dose
Sponsors
Boehringer Ingelheim
Conditions
Healthy
Phase 1
Study to Assess Safety, Tolerability and Pharmacokinetics of Single Rising Doses of BEA 2180 BR in Healthy Male Volunteers
CompletedNCT02254135
Start: 2006-12-31Updated: 2014-10-01
Study to Evaluate Safety, Tolerability and Pharmacokinetics of Multiple Rising of BEA 2180 BR in Japanese Healthy Male Volunteers
CompletedNCT02254109
Start: 2008-04-30Updated: 2014-10-01